Bemarituzumab
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
FGFR
CAS Number
1952272-74-0
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Mouse Monoclonal GITR/TNFRSF18 Antibody (T9P4G4-D7) [Alexa Fluor 750]](https://cdn.genprice.uk/genprice/genprice4.png)
NBP2-50337AF750 0.1 mL
Mouse Monoclonal GITR/TNFRSF18 Antibody (T9P4G4-D7) [Alexa Fluor 750]
Ask
View Details 
HEL059Hu-01 24 Tests
High Sensitive ELISA Kit for Parkinson Disease Protein 7 (PARK7)
Ask
View Details HEL059Hu-02 48 Tests
High Sensitive ELISA Kit for Parkinson Disease Protein 7 (PARK7)
Ask
View Details HEL059Hu-03 96 Tests
High Sensitive ELISA Kit for Parkinson Disease Protein 7 (PARK7)
Ask
View Details HEL059Hu-04 5x 96 Tests
High Sensitive ELISA Kit for Parkinson Disease Protein 7 (PARK7)
Ask
View Details